Know Cancer

or
forgot password

Monitoring Plasma and Hemodynamic Markers in Patients Undergoing Liver Resection to Identify Pathophysiological Mechanisms and Predict Clinical Outcome


N/A
18 Years
85 Years
Open (Enrolling)
Both
Hepatorenal Syndrome, Liver Regeneration

Thank you

Trial Information

Monitoring Plasma and Hemodynamic Markers in Patients Undergoing Liver Resection to Identify Pathophysiological Mechanisms and Predict Clinical Outcome


Inclusion Criteria:



- Patient with neoplastic liver tumors undergoing elective hepatectomy.

Exclusion Criteria:

- Non elective hepatic surgery, preoperative HVPG > 10 mmHG, preoperative renal failure

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Edith Fleischmann, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Medical University of Vienna

Authority:

Austria: Medical University of Vienna

Study ID:

HVPG/Liver Regeneration Study

NCT ID:

NCT01700231

Start Date:

October 2010

Completion Date:

Related Keywords:

  • Hepatorenal Syndrome, Liver Regeneration
  • hepatorenal syndrome, liver regeneration, liver dysfunction
  • Hepatorenal Syndrome

Name

Location